Eduardo Ruiz Hernández is an ERC awardee and Associate Professor in Pharmaceutical Chemistry of Nanocarrier Drug Delivery Systems in the School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin.
Over the past 17 years, he has participated in 26 highly multidisciplinary collaborative projects funded by a variety of national and international sources (EU FP6/FP7/H2020, BBSRC, SFI, CTMM The Netherlands, Spanish MICIIN, CIBER-BBN) across 7 countries in diverse scientific fields including nanomedicine, materials chemistry, drug/gene delivery and tissue engineering.
His research programme aims to design responsive nanosystems with disease-specific theranostic potential. These systems will dramatically impact the targeted release of diagnostic agents and drugs with nanomedicines that respond to biological cues or changing pathophysiological conditions, thus enabling ultrasensitive diagnosis and exquisite therapy selectivity.
AMBER has a strong emphasis on collaboration. Central to AMBER’s research remit are collaborative projects performed with industry partners, and working with academic, industry and wider stakeholder on international and national research programmes.Get in touch